OKYO Pharma Limited (LON:OKYO – Get Free Report) dropped 24.3% during mid-day trading on Tuesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). Approximately 364,142 shares changed hands during trading, a decline of 16% from the average daily volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).
OKYO Pharma Price Performance
The company has a quick ratio of 2.65, a current ratio of 0.83 and a debt-to-equity ratio of 1.65. The company has a market capitalization of £23.24 million, a price-to-earnings ratio of -140.00 and a beta of -0.06. The business’s 50-day moving average is GBX 1.40 and its 200-day moving average is GBX 1.40.
About OKYO Pharma
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
Further Reading
- Five stocks we like better than OKYO Pharma
- The How And Why of Investing in Oil Stocks
- Comprehensive PepsiCo Stock Analysis
- What Do S&P 500 Stocks Tell Investors About the Market?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Most active stocks: Dollar volume vs share volume
- Bear Market Funds to Watch This Year
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
